» Articles » PMID: 19593102

Vitamin D Deficiency and Risk for Cardiovascular Disease

Overview
Journal Am J Med Sci
Publisher Elsevier
Specialty General Medicine
Date 2009 Jul 14
PMID 19593102
Citations 132
Authors
Affiliations
Soon will be listed here.
Abstract

Vitamin D is an important prohormone for optimal intestinal calcium absorption for mineralization of bone. Because the vitamin D receptor is present in multiple tissues, there has been interest in evaluating other potential functions of vitamin D, particularly, in cardiovascular diseases (CVD). Cross-sectional studies have reported that vitamin D deficiency is associated with increased risk of CVD, including hypertension, heart failure, and ischemic heart disease. Initial prospective studies have also demonstrated that vitamin D deficiency increases the risk of developing incident hypertension or sudden cardiac death in individuals with preexisting CVD. Very few prospective clinical studies have been conducted to examine the effect of vitamin D supplementation on cardiovascular outcomes. The mechanism for how vitamin D may improve CVD outcomes remains obscure; however, potential hypotheses include the downregulation of the renin-angiotensin-aldosterone system, direct effects on the heart, and vasculature or improvement of glycemic control. This review will examine the epidemiologic and clinical evidence for vitamin D deficiency as a cardiovascular risk factor and explore potential mechanisms for the cardioprotective effect of vitamin D.

Citing Articles

A Narrative Review of the Role of Blood Biomarkers in the Risk Prediction of Cardiovascular Diseases.

Garady L, Soota A, Shouche Y, Chandrachari K, K V S, Shankar P Cureus. 2025; 16(12):e74899.

PMID: 39742176 PMC: 11688159. DOI: 10.7759/cureus.74899.


The Co-Existence of Hypovitaminosis D and Diabetes Mellitus Triples the Incidence of Severe Coronary Artery Disease in Women.

Aleksova A, Janjusevic M, Pani B, Hiche C, Chicco A, Derin A J Clin Med. 2024; 13(22).

PMID: 39597936 PMC: 11594877. DOI: 10.3390/jcm13226792.


Vitamin D: A key player in COVID-19 immunity and lessons from the pandemic to combat immune-evasive variants.

Sabit H, Abdel-Ghany S, Abdallah M, Abul-Maaty O, Khoder A, Shoman N Inflammopharmacology. 2024; 32(6):3631-3652.

PMID: 39406981 PMC: 11550250. DOI: 10.1007/s10787-024-01578-w.


The Efficacy of Vitamins in the Prevention and Treatment of Cardiovascular Disease.

Tappia P, Shah A, Dhalla N Int J Mol Sci. 2024; 25(18).

PMID: 39337248 PMC: 11432297. DOI: 10.3390/ijms25189761.


Ambient ultraviolet radiation as a cardioprotective factor: A global and regional analysis.

You W Health Sci Rep. 2024; 7(9):e70065.

PMID: 39286740 PMC: 11403301. DOI: 10.1002/hsr2.70065.


References
1.
Trivedi D, Doll R, Khaw K . Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ. 2003; 326(7387):469. PMC: 150177. DOI: 10.1136/bmj.326.7387.469. View

2.
Forman J, Giovannucci E, Holmes M, Bischoff-Ferrari H, Tworoger S, Willett W . Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007; 49(5):1063-9. DOI: 10.1161/HYPERTENSIONAHA.107.087288. View

3.
Chonchol M, Scragg R . 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int. 2006; 71(2):134-9. DOI: 10.1038/sj.ki.5002002. View

4.
Douglas A, Dunnigan M, ALLAN T, Rawles J . Seasonal variation in coronary heart disease in Scotland. J Epidemiol Community Health. 1995; 49(6):575-82. PMC: 1060171. DOI: 10.1136/jech.49.6.575. View

5.
Scragg R, Khaw K, Murphy S . Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults. Eur J Clin Nutr. 1995; 49(9):640-6. View